Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP957141.RAGszvjCOr6hySdzBw0gRT6vDr0oAPLJ_Un5sAb6tBopU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP957141.RAGszvjCOr6hySdzBw0gRT6vDr0oAPLJ_Un5sAb6tBopU130_assertion type Assertion NP957141.RAGszvjCOr6hySdzBw0gRT6vDr0oAPLJ_Un5sAb6tBopU130_head.
- NP957141.RAGszvjCOr6hySdzBw0gRT6vDr0oAPLJ_Un5sAb6tBopU130_assertion description "[We concluded that ECRG2 is a potential molecular target in biological therapy strategies for cancer treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP957141.RAGszvjCOr6hySdzBw0gRT6vDr0oAPLJ_Un5sAb6tBopU130_provenance.
- NP957141.RAGszvjCOr6hySdzBw0gRT6vDr0oAPLJ_Un5sAb6tBopU130_assertion evidence source_evidence_literature NP957141.RAGszvjCOr6hySdzBw0gRT6vDr0oAPLJ_Un5sAb6tBopU130_provenance.
- NP957141.RAGszvjCOr6hySdzBw0gRT6vDr0oAPLJ_Un5sAb6tBopU130_assertion SIO_000772 23079671 NP957141.RAGszvjCOr6hySdzBw0gRT6vDr0oAPLJ_Un5sAb6tBopU130_provenance.
- NP957141.RAGszvjCOr6hySdzBw0gRT6vDr0oAPLJ_Un5sAb6tBopU130_assertion wasDerivedFrom befree-20150227 NP957141.RAGszvjCOr6hySdzBw0gRT6vDr0oAPLJ_Un5sAb6tBopU130_provenance.
- NP957141.RAGszvjCOr6hySdzBw0gRT6vDr0oAPLJ_Un5sAb6tBopU130_assertion wasGeneratedBy ECO_0000203 NP957141.RAGszvjCOr6hySdzBw0gRT6vDr0oAPLJ_Un5sAb6tBopU130_provenance.